Gujarat Themis Biosyn Limited

Bank of India Mutual Fund added over 0.63% of Gujarat Themis Biosyn Limited and now holds 1.63%, or 21,18,645 shares.

A pharmaceutical manufacturer incorporated in 1981, Gujarat Themis Biosyn produces finished Active Pharmaceutical Ingredients through advanced fermentation-based processes. The company specializes in biosynthetic drug compounds for both domestic and international markets. Its proprietary fermentation expertise, vertical integration in API manufacturing, and focus on complex molecule production distinguish it within India's competitive pharmaceutical sector.

AMC subsidiary of Bank of India, one of India's oldest public sector banks founded in 1906. Manages over Rs 20,000 crore with a range of equity, debt and hybrid offerings. Distributes through Bank of India's 5,000+ branch network giving it reach into Tier 2 and Tier 3 cities that larger private AMCs find harder to access.